Abstract
A novel injectable pre-exposure prophylaxis, cabotegravir, has greater efficacy and acceptability than oral tenofovir/emtricitabine for prevention of ......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
